Elan Announces Plan to Spin-Off Discovery Science And Neotope Biosciences to Shareholders
02:00 EDT 13 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Elan Corporation, plc (NYSE:ELN) announced today that its Board of
Directors has approved the spin-off of the discovery science and Neotope
Biosciences from the company. Completion of this transaction will create
two independent...
Other Sources for this Article
Elan Corporation, plc
Investor Relations:
Chris
Burns, 800-252-3526
David Marshall, + 353-1-709-4444
or
Media
Relations:
Emer Reynolds, + 353-1-709-4022
Jonathan Birt,
+44-751-559-7858
Jamie Tully, +1-212-687-8080
More From BioPortfolio on "Elan Announces Plan to Spin-Off Discovery Science And Neotope Biosciences to Shareholders"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
